Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study is meant to assess the effect of IW-3718 as an added treatment to ongoing
once-daily protocol pump inhibitor (PPI) treatment for patients who continue to experience
symptoms of their gastroesophageal reflux disease (GERD).